SCHEMBL5219656

SCHEMBL5219656

COc1c([N+](=O)[O-])cc(C(=O)O)c(C)c1NC(=O)CCCCl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
L3MBTL1 Q9Y468 2/20 0.41
CYP1A2 P05177 2/20 0.41
CYP3A4 P08684 2/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
TPMT P51580 1/20 0.40
NPC1 O15118 2/20 0.38
TSHR P16473 1/20 0.38
CTSV O60911 1/20 0.38
CTSL P07711 1/20 0.38
PKM P14618 1/20 0.38
IMPDH2 P12268 1/20 0.38
RAB9A P51151 1/20 0.38
MAPT P10636 4/20 0.37
KMT2A Q03164 4/20 0.37
MEN1 O00255 3/20 0.37
POLB P06746 1/20 0.37
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22835448 0.74 TPMT (0.55) ALDH1A1TPMTTSHRPKMIMPDH2
SCHEMBL5219650 0.73 HTT (0.45) ALDH1A1L3MBTL1CYP1A2CYP3A4CYP2D6
SCHEMBL159719 0.72 MAPT (0.44) ALDH1A1L3MBTL1CYP1A2CYP3A4CYP2C9
SCHEMBL3471542 0.71 TSHR (0.53) ALDH1A1L3MBTL1TPMTTSHRPKM
SCHEMBL18940600 0.71 TSHR (0.47) ALDH1A1TPMTTSHRCTSVCTSL
SCHEMBL23978047 0.71 TPMT (0.51) ALDH1A1CYP1A2CYP2D6CYP2C19TPMT
SCHEMBL5225589 0.70 ALDH1A1 (0.49) ALDH1A1L3MBTL1CYP1A2CYP3A4CYP2D6
SCHEMBL1975251 0.69 LMNA (0.45) ALDH1A1CYP2C9TPMTTSHRPKM
SCHEMBL31447572 0.69 TPMT (0.52) ALDH1A1TPMTTSHRPKMIMPDH2
SCHEMBL5220176 0.69 TSHR (0.36) L3MBTL1TSHRMAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567488-B1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LTD (GB) 2007-02-21 EP disclosed